|
|
||||||||
American Journal of Clinical Nutrition, Vol 62, 1245-1251, Copyright © 1995 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
A Lia, G Hallmans, AS Sandberg, B Sundberg, P Aman and H Andersson
Department of Clinical Nutrition, University of Goteborg, Sweden.
The purpose of this study was to investigate whether oat beta-glucan is responsible for the increased bile acid excretion previously observed with oat-fiber diets. The excretion patterns in ileostomy subjects given diets containing oat-bran bread with and without added beta- glucanase, a beta-glucan-degrading enzyme, were compared. The effect of a beta-glucan-rich barley fraction on sterol excretion was also investigated. Nine ileostomy subjects were served four diets in random order, each diet for 2 consecutive days. Four different kinds of bread, mainly made from oat bran (OB diet, 12.5 g beta-glucan/d), oat bran with beta-glucanase (OBE diet, 3.8 g beta-glucan/d), barley (B diet, 13.0 g beta-glucan/d), or wheat flour (W diet, 1.2 g beta-glucan/d) were added to a basal diet. The 24-h excretion of bile acids was 53% higher in the OB diet period than in the OBE diet period (P < 0.05) and also was significantly higher than in the B and W diet periods (P < 0.05). Median (range) bile acid excretion was 851 (232-1550), 463 (123- 1414), 755 (133-1187), and 606 (101-980) mg/d in the OB, OBE, B, and W diet periods, respectively. The excretion of cholesterol was significantly higher in the B diet period than in the OBE and W diet periods (P < 0.05), but the mechanism behind this effect of barley fiber is unknown. In oat bran, however, beta-glucan mediates an increase in bile acid excretion, which most probably explains the effect of oat fiber in lowering serum lipids.
This article has been cited by other articles:
![]() |
N. P. Ames and C. R. Rhymer Issues Surrounding Health Claims for Barley J. Nutr., June 1, 2008; 138(6): 1237S - 1243S. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Theuwissen and R. P. Mensink Simultaneous Intake of {beta}-Glucan and Plant Stanol Esters Affects Lipid Metabolism in Slightly Hypercholesterolemic Subjects J. Nutr., March 1, 2007; 137(3): 583 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Naumann, A. B van Rees, G. Onning, R. Oste, M. Wydra, and R. P Mensink {beta}-Glucan incorporated into a fruit drink effectively lowers serum LDL-cholesterol concentrations Am. J. Clinical Nutrition, March 1, 2006; 83(3): 601 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Frank, B. Sundberg, A. Kamal-Eldin, B. Vessby, and P. Aman Yeast-Leavened Oat Breads with High or Low Molecular Weight {beta}-Glucan Do Not Differ in Their Effects on Blood Concentrations of Lipids, Insulin, or Glucose in Humans J. Nutr., June 1, 2004; 134(6): 1384 - 1388. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. F Keogh, G. J. Cooper, T. B Mulvey, B. H McArdle, G. D Coles, J. A Monro, and S. D Poppitt Randomized controlled crossover study of the effect of a highly {beta}-glucan-enriched barley on cardiovascular disease risk factors in mildly hypercholesterolemic men Am. J. Clinical Nutrition, October 1, 2003; 78(4): 711 - 718. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Gujral, S. Gaur, and C. M. Rosell Note: Effect of Barley Flour, Wet Gluten and Ascorbic Acid on Bread Crumb Texture Food Science and Technology International, February 1, 2003; 9(1): 17 - 21. [Abstract] [PDF] |
||||
![]() |
G. Dongowski, M. Huth, E. Gebhardt, and W. Flamme Dietary Fiber-Rich Barley Products Beneficially Affect the Intestinal Tract of Rats J. Nutr., December 1, 2002; 132(12): 3704 - 3714. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Andersson, L. Ellegard, and H. Andersson Oat bran stimulates bile acid synthesis within 8 h as measured by 7{alpha}-hydroxy-4-cholesten-3-one Am. J. Clinical Nutrition, November 1, 2002; 76(5): 1111 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hermansen, M. Søndergaard, L. Høie, M. Carstensen, and B. Brock Beneficial Effects of a Soy-Based Dietary Supplement on Lipid Levels and Cardiovascular Risk Markers in Type 2 Diabetic Subjects Diabetes Care, February 1, 2001; 24(2): 228 - 233. [Abstract] [Full Text] |
||||
![]() |
C. M. Gallaher, J. Munion, R. Hesslink Jr., J. Wise, and D. D. Gallaher Cholesterol Reduction by Glucomannan and Chitosan Is Mediated by Changes in Cholesterol Absorption and Bile Acid and Fat Excretion in Rats J. Nutr., November 1, 2000; 130(11): 2753 - 2759. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. B. Andersson, L. H. Ellegård, and I. G. Bosaeus Nondigestibility Characteristics of Inulin and Oligofructose in Humans J. Nutr., July 1, 1999; 129(7): 1428 - 1428. [Abstract] [Full Text] |
||||
![]() |
I. Bourdon, W. Yokoyama, P. Davis, C. Hudson, R. Backus, D. Richter, B. Knuckles, and B. O Schneeman Postprandial lipid, glucose, insulin, and cholecystokinin responses in men fed barley pasta enriched with ß-glucan Am. J. Clinical Nutrition, January 1, 1999; 69(1): 55 - 63. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Romero, J. E. Romero, S. Galaviz, and M. L. Fernandez Cookies Enriched with Psyllium or Oat Bran Lower Plasma LDL Cholesterol in Normal and Hypercholesterolemic Men from Northern Mexico J. Am. Coll. Nutr., December 1, 1998; 17(6): 601 - 608. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |